tm
Seeing Is Believing
tm
Seeing Is Believing
MNPR is currently covered by 8 analysts with an average price target of $109.94. This is a potential upside of $28.28 (-5.62%) from yesterday's end of day stock price of $116.49.
Monopar Therapeutics's activity chart (see below) currently has 22 price targets and 46 ratings on display. The stock rating distribution of MNPR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 73.79% with an average time for these price targets to be met of 273.8 days.
Highest price target for MNPR is $133, Lowest price target is $93, average price target is $109.94.
Most recent stock forecast was given by JEET MUKHERJEE from BTIG on 12-Aug-2026. First documented stock forecast 24-Sep-2020.
Currently out of the existing stock ratings of MNPR, 24 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Sep-2025
$133
$19.96 (17.66%)
$117
Buy Since 23-Jun-2025
$100
$12.32 (14.05%)
$100
Buy Since 10-Jan-2025
$123
$35.32 (40.28%)
$142
Buy Since 10-Oct-2025
$130
$42.32 (48.27%)
$2
Buy Since 03-Sep-2025
$115
$27.32 (31.16%)
$77
What is MNPR (Monopar Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MNPR (Monopar Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MNPR (Monopar Therapeutics)?
Which analyst is the currently most bullish on MNPR (Monopar Therapeutics)?
Which analyst is the currently most reserved on MNPR (Monopar Therapeutics)?
